Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
<p>Background: Primaquine is the only licensed drug for eradicating Plasmodium vivax hypnozoites and, therefore, preventing relapses of vivax malaria. It is a vital component of global malaria elimination efforts. Primaquine is efficacious when supervised in clinical trials, but its effective...
Hlavní autoři: | Douglas, NM, Poespoprodjo, JR, Patriani, D, Malloy, MJ, Kenangalem, E, Sugiarto, P, Simpson, JA, Soenarto, Y, Anstey, NM, Price, RN |
---|---|
Další autoři: | Garner, P |
Médium: | Journal article |
Vydáno: |
Public Library of Science
2017
|
Podobné jednotky
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Autor: Setyadi, A, a další
Vydáno: (2019) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
Autor: Thriemer, K, a další
Vydáno: (2020) -
High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
Autor: Kho, S, a další
Vydáno: (2018) -
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Autor: Agus Setyadi, a další
Vydáno: (2019-04-01) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
Autor: Kamala Thriemer, a další
Vydáno: (2020-11-01)